Bronchiectasis

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 17

BRONCHIECTASI

S
Definition

 Bronchiectasis is characterized by permanent , abnormal


dilation of one or more large bronchi.
Or
Bronchiectasis is a chronic , irreversible dilation of the bronchi
and bronchioles .
Etiopathophysiology

 The pathophysiogic change that results in dilation is


destruction of the elastic and muscular structures supporting
the bronchial wall.
 The disease process results in a reduced ability to clear
mucus from the lungs and decreased expiratory air.
 The variety of pathophysiogic process can result in bronchiectasis.
 Primary disorders of structures in the bronchi.
 Disease of mucus clearance (cystic fibrosis) infections.
 Etiologies (severe childhood bronchial infections ) and inflammatory
disease (ulcerative colitis).
 Diffuse airway injury.
 Pulmonary infections (complications of long term pulmonary
infection).
 Genetic disorder( cystic fibrosis).
 Abnormal host defence.
 Idiopathic cause.
Types of Bronchiactasis
1. Cylindrical or Tubular – dilatation is mild & both bronchi retain their
regular relatively straight outline.
2. Varicose – Is greater and local constrictions are present .
3. Saccular / cystic – Most severe form & is characterized by large areas of
distal ‘ grape like’ bronchial dilatation & loss of bronchial subdivision.
SIGN & SYMPTOMS
 Cough & daily mucopurulent sputum production, often lasting month
to years.
 Blood streaked sputum or hemoptysis from airway damage associated
with acute infection.
 Dyspnea , pleuritic chest pain , wheezing , fever, weakness, fatigue &
weight loss.

Exacerbation of bronchiectasis from acute bacterial infections may


produce the following –
 Increased sputum production over baseline .
 A foul odour of sputum.
 Low grade fever.
 Increased shortness of breath , dyspnea , wheezing or pleuritic pain.
Findings on physical examination are nonspecific and may
include the following :

 Crackles , rhonchi , scattered wheezing & inspiratory squeaks on


auscultation.
 Digital clubbing 2- 3% of patients .
 Cynosis and plethora with polycythemia from chronic hypoxia
 Wasting and weight loss.
 Nasal polyp and sings of chronic sinusitis.
INVESTIGATION

1. CBC Count
2. Sputum analysis.
3. Chest x-ray
4. Computes tomography.
5. Quantitative immunoglobulin levels
6. Quantitative alpha 1-antitrypsin levels.
7. Sweat test
8. PFT
MANAGEMENT

 SUPPORTIVE TREATMENT –
 Smoking cessation
 Adequate nutritional intake with supplementation , if necessary
 Immunization for influenza and pneumococcal pneumonia .
 Confirmation of immunization for measles , rubella and pertussis.
 Oxygen therapy is reserved for patients who are hypoxemic with severe
disease and end stage complications such as cor pulmonale.
 ANTIBIOTIC THERAPY :

Acceptable choices for the outpatient who is mild to moderately ill include any
of the following

 Amoxicillin
 Tetracycline
 Azithromycin or clarithromycin
 A 2nd generation cephalosporine
 Fluroquinolone.
In gen. the duration of antibiotic therapy for mild to moderate illness is 7-10
days.
For patients with moderate to severe symptoms

Parenteral antibiotics such as an aminoglycoside


 Gentamycin , Tobramycin
 3rd gen cephalosporin
 Fluroquinolone

 H-influenzae , H-parainfluenzae – most common organism


Amoxicillin 500mg tds for 10 – 14 days.
Ps.Aeruginosa common in severe disease – ciprofloxacin 500mg bd for 2 week
I.V. antibiotics – ceftadizime 2gm tds ,
gentamicin
Acute exacerbations
Hospitalization in all severely ill patients , when chest pain limits coughing and
sputum clearence ( this increases risk of pneumonia ) and iv antibiotics are
required .

Prophylactic therapy
One guideline for therapy is when there are exacerbation every 2 months that
prevent participation in normal activation of 2 weeks or more during the
exacerbation .
Continuous therapy is considered in patients who persistently expectorate purulent
sputum . aggressive treatment is warranted because persistent infection causes
tissue destruction.
Bilateral lung transplantation has been used when respiratory failure develops
despite optimal medical management.
General supportive treatment

 Adequate nutrition
 Eradication of chronic nocturnal post- nasal discharge and
treatment of sinusitis.
 Avoidance of smoking.
 Adequate hydration.
Surgical

Indication for surgical resection.

 Bronchiactasis confined to one segment or lobe of the lung causing


recurrent or persistent symptoms.
 Uncontrollable hemoptysis ( excision or bronchial artery embolization)
 Occasionally for chronic fungal superinfection e.g.aspergilloma.
THANK YOU !

You might also like